JP2017522392A5 - - Google Patents

Download PDF

Info

Publication number
JP2017522392A5
JP2017522392A5 JP2016565146A JP2016565146A JP2017522392A5 JP 2017522392 A5 JP2017522392 A5 JP 2017522392A5 JP 2016565146 A JP2016565146 A JP 2016565146A JP 2016565146 A JP2016565146 A JP 2016565146A JP 2017522392 A5 JP2017522392 A5 JP 2017522392A5
Authority
JP
Japan
Prior art keywords
heparan sulfate
isolated
substantially purified
polypeptide
purified heparan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016565146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017522392A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2015/050092 external-priority patent/WO2015167401A1/en
Publication of JP2017522392A publication Critical patent/JP2017522392A/ja
Publication of JP2017522392A5 publication Critical patent/JP2017522392A5/ja
Pending legal-status Critical Current

Links

JP2016565146A 2014-04-30 2015-04-30 ヘパラン硫酸 Pending JP2017522392A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG10201401967W 2014-04-30
SG10201401967W 2014-04-30
PCT/SG2015/050092 WO2015167401A1 (en) 2014-04-30 2015-04-30 Heparan sulphates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020082462A Division JP7145909B2 (ja) 2014-04-30 2020-05-08 ヘパラン硫酸

Publications (2)

Publication Number Publication Date
JP2017522392A JP2017522392A (ja) 2017-08-10
JP2017522392A5 true JP2017522392A5 (enExample) 2018-06-14

Family

ID=54358977

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016565146A Pending JP2017522392A (ja) 2014-04-30 2015-04-30 ヘパラン硫酸
JP2020082462A Active JP7145909B2 (ja) 2014-04-30 2020-05-08 ヘパラン硫酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020082462A Active JP7145909B2 (ja) 2014-04-30 2020-05-08 ヘパラン硫酸

Country Status (11)

Country Link
US (1) US10596296B2 (enExample)
EP (1) EP3137509A4 (enExample)
JP (2) JP2017522392A (enExample)
KR (1) KR20170013255A (enExample)
CN (1) CN107001488B (enExample)
AU (1) AU2015253870B2 (enExample)
BR (1) BR112016025443A2 (enExample)
IL (1) IL248608A0 (enExample)
MX (1) MX2016014202A (enExample)
SG (1) SG11201609026UA (enExample)
WO (1) WO2015167401A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170013255A (ko) * 2014-04-30 2017-02-06 에이전시 포 사이언스, 테크놀로지 앤드 리서치 헤파란 설페이트
CN107530371B (zh) 2015-01-09 2021-10-26 新加坡科技研究局 硫酸乙酰肝素的pdgf-b/pdgf-bb结合变体
CN108508129B (zh) * 2018-04-03 2020-11-27 青岛海洋生物医药研究院股份有限公司 一种肝素类药物生物效价的测定方法
CN110646548A (zh) * 2019-10-18 2020-01-03 福州大学 一种提取阿胶中肝素/硫酸类肝素二糖的方法
JPWO2024080183A1 (enExample) * 2022-10-14 2024-04-18

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019087A (en) 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5843442A (en) * 1990-10-22 1998-12-01 Corvas International, Inc. Blood coagulation protein antagonists and uses therefor
US5807982A (en) * 1991-04-29 1998-09-15 Cornell Research Foundation, Inc. Affinity purified heparin
WO1996023003A1 (en) 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
KR100688871B1 (ko) * 2002-03-12 2007-03-02 티슈진, 인코포레이티드 연골세포 및 TGF-β를 사용한 연골 재생
ITTO20060282A1 (it) * 2006-04-14 2007-10-15 Univ Degli Studi Torino Mezzo di coltura e composizione farmaceutica per la rigenerazione del tessuto cartilagineo relativo procedimento relativi usi e prodotti
US9498494B2 (en) 2008-09-11 2016-11-22 Agency For Science, Technology And Research Glycosaminoglycans
GB0818255D0 (en) 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
US9359452B2 (en) 2009-11-20 2016-06-07 Agency For Science, Technology And Research Isolation and characterisation of heparan sulphates and their use in pharmaceutical compositions, methods of treatment and stem cell culture media suitable for conditions associated with bone repair
US20130071443A1 (en) 2011-09-16 2013-03-21 Agency For Science, Technology And Research Glycosaminoglycans
CA2856492C (en) * 2011-12-19 2017-01-10 Dilafor Ab Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
KR20170013255A (ko) * 2014-04-30 2017-02-06 에이전시 포 사이언스, 테크놀로지 앤드 리서치 헤파란 설페이트

Similar Documents

Publication Publication Date Title
KR102236805B1 (ko) Hc-ha/ptx3 복합체를 함유하는 조성물 및 이의 사용 방법
CA2721507C (en) Methods of generating and using procollagen
Einhorn Enhancement of fracture-healing.
Piccoli et al. Improvement of diaphragmatic performance through orthotopic application of decellularized extracellular matrix patch
Nam et al. Synergistic effects of laminin-1 peptides, VEGF and FGF9 on salivary gland regeneration
JP5607176B2 (ja) 新規ペプチドおよびその用途
Lee et al. Human umbilical cord blood–derived mesenchymal stromal cells and small intestinal submucosa hydrogel composite promotes combined radiation-wound healing of mice
Pereira et al. Effects of human mesenchymal stem cells isolated from Wharton’s jelly of the umbilical cord and conditioned media on skeletal muscle regeneration using a myectomy model
US20120171257A1 (en) Cell-guiding fibroinductive and angiogenic scaffolds for periodontal tissue engineering
KR20100035648A (ko) 체외 배양 및 증식 자기재생성 집락 형성 세포를 이용한 질환 및 장애 치료방법
RU2015153735A (ru) Гепарансульфаты
CN111097066A (zh) 一种能够抑制疤痕产生的促伤口愈合医用敷料及其制备方法
Wu et al. Rat bone marrow mesenchymal stem cells induced by rrPDGF-BB promotes bone regeneration during distraction osteogenesis
Fu et al. Fish Swim Bladder‐Derived ECM Hydrogels Effectively Treat Myocardial Ischemic Injury through Immunomodulation and Angiogenesis
CA3198813A1 (en) Novel bioactive peptide combinations and uses thereof
Kim et al. Regeneration of paralyzed vocal fold by the injection of plasmid DNA complex-loaded hydrogel bulking agent
US20230010110A1 (en) Histatin-1 formulation for the treatment, repair or regeneration of bone tissue in a subject
Turner et al. Human NELL1 protein augments constructive tissue remodeling with biologic scaffolds
Friedman et al. Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair
US20260069745A1 (en) Biologic composition for promoting wound healing and a method of preparing the same
Crisci et al. Blood platelets in tissue regeneration: Narrative review
Delecave Dias Effects Of Cell-Free Conditioned Media on Healing of Rat Achilles Tendon
US9662417B2 (en) Medical device
Wan et al. Multi‐Omics Profiling Reveals Immunomodulatory and Pro‐Regenerative Effects of a Graphene Oxide–Collagen Scaffold in Massive Rotator Cuff Tears
Ettey An investigation of collagen, platelet-rich plasma and bone marrow derived mesenchymal stem cells on Achilles tendon repair in a rat model